SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-13-000871
Filing Date
2013-02-26
Accepted
2013-02-26 14:27:07
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2012_soligenix.htm 10-K 1283545
2 ACCOUNTANTS CONSENT f10k2012ex23i_soligenix.htm EX-23.1 4110
3 CERTIFICATION f10k2012ex31i_soligenix.htm EX-31.1 14061
4 CERTIFICATION f10k2012ex31ii_soligenix.htm EX-31.2 14046
5 CERTIFICATION f10k2012ex32i_soligenix.htm EX-32.1 5850
6 CERTIFICATION f10k2012ex32ii_soligenix.htm EX-32.2 6065
  Complete submission text file 0001213900-13-000871.txt   6102937

Data Files

Seq Description Document Type Size
7 sngx-20121231.xml EX-101.INS 826810
8 sngx-20121231.xsd EX-101.SCH 44626
9 sngx-20121231_cal.xml EX-101.CAL 40024
10 sngx-20121231_def.xml EX-101.DEF 148771
11 sngx-20121231_lab.xml EX-101.LAB 370134
12 sngx-20121231_pre.xml EX-101.PRE 288497
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16929 | Film No.: 13642075
SIC: 2834 Pharmaceutical Preparations